The Pharmaceutical Journal
Vol 269 No 7223 p676
9 November 2002

This page
Reprint
Photocopy

PDF 55K

  Academic pharmacists
  Patient packs
  Community pharmacists
  Antibiotics
  The Society
  CPD
  The Journal

Letters to the Editor

Antibiotics

Growing interest in phage therapy

From Ms A. E. Henein, MRPharmS, and others

In response to your recent news feature (PDF 89K), “Pharmageddon: is it too late to tackle growing resistance to anti-infectives?”(PJ, 26 October, p599), we would like to point out that the School of Pharmacy and Biomolecular Sciences at the University of Brighton is undertaking a project on the control of multiple antibiotic resistant Acinetobacter species. The aim is to breed promiscuous bacteriophages as a biological approach to the treatment of Acinetobacter spp infections in burns patients. This project is supported by a Royal Pharmaceutical Society studentship and follows on from similar projects investigating the use of bacteriophages for the treatment of Pseudomonas aeruginosa infection.

There is growing international interest in the use of phage therapy for the treatment of bacterial infection in circumstances where antibiotic control fails. Readers who wish to know more may like to consult the British Pharmaceutical Conference Science Chairman’s recent address (PDF 240K), published in The Pharmaceutical Journal (28 September, p451).

Alexandra Henein
Postgraduate Research Student

Geoff Hanlon
Reader

Stephen P. Denyer
Head,
School of Pharmacy and Biomolecular Sciences,
University of Brighton

Send your letter to The Editor

Previous Topic (Community pharmacists)
Next Topic (The Society)